Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:40 PM
Ignite Modification Date:
2025-12-26 @ 2:40 PM
NCT ID:
NCT03163706
Eligibility Criteria:
Inclusion Criteria:
For both:
* MMSE score greater than or equal to, 22 if no grade ; 23 if study certificate or CAP or college without patent ; 25 if patent or school without the tray ; 26 or more when bin
* IQ ≥ 75 (fNART)
* Lextale score ≥ 28
* Age: between 18 and 45 years
For patients :
* DSM-5 criteria of schizophrenia
* Patients followed as outpatients,
* Age of onset of the disease less than 40 years,
* Patients whose disease has stabilized: no changes psychotropic treatment for at least 1 month
* Not more of a benzodiazepine,
* Patients on protection of justice or not,
For controls :
* Matched for sex to patient
* Age-matched (+/- 3 years) to patient
* Matched for IQ (score fNART +/- 10% to patients
* Matched for Lextale score+/- 10% to patients
Exclusion Criteria:
For patients :
* Any other comorbid psychiatric diagnosis of Axis I DSM-5
* Extrapyramidal syndrome or tardive dyskinesia (AIMS score \<2 BARS score \<2 and score Simpson and Angus \<3)
* Calgary depression scale ≥ 6
* Current or past addiction to all toxic substances (including alcohol and cannabis) except tobacco.
* Current or past use of all toxic consumption (excluding alcohol, tobacco and cannabis).
* Use of alcohol or cannabis before the age of 15 years
* Alcohol abuse in the past 6 months.
* Cannabis abuse in the past 6 months and cannabis use in the last 3 months.
* Patients with impaired vision or hearing preventing the realization of the tests.
For controls:
* Any psychiatric diagnosis according to DSM-5, including addictions (excluding tobacco)
* Score HADS Anxiety ≥ 8 and Depression ≥ 8
* SCL90R: global severity score GSI\> 0.33 for women and\> 0.27 for men, or score diversity PST symptoms\> 18.49 for men and\> 21.97 for women or score of degree of discomfort PSDI\> 1.27 for men and\> 1.3 for women, scoring in the subscale Psychotic Features\> 0.
* Presence of a personality disorder at PDQ4 +
* Head injuries, brain injuries or diseases,
* vision or hearing problems preventing the realization of the tests.
* Current or past addiction to all toxic substances (including alcohol and cannabis) except tobacco.
* Current or past use of all toxic consumption (excluding alcohol, tobacco and cannabis).
* Long-term Anticholinergic treatment.
* Related to the first degree diagnosed with a psychotic disorder
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT03163706
Study Brief:
Protocol Section:
NCT03163706